Transaction in Own Shares

Close this window

Transaction in Own Shares

05/12/2026

RNS Number : 8468D

Fevertree Drinks PLC

12 May 2026

12^th May 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5^th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 5^th May to 8^th May 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
05 May 2026	XLON	808.7628	41,756	797.5000	822.0000
06 May 2026	XLON	822.7491	37,168	811.0000	830.5000
06 May 2026	AIMX	821.0000	4,317	821.0000	821.0000
07 May 2026	XLON	817.3505	19,617	811.5000	824.0000
07 May 2026	AIMX	823.5500	15,000	823.5500	823.5500
08 May 2026	XLON	811.8708	35,618	807.0000	817.0000

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/8468D_1-2026-5-11.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For further information please contact:

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSXFLFFQELZBBK

Multimedia Files:

Close this window